| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.4 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.4 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |